Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Entrada Therapeutics (TRDA) Shares Issued: 2022-2025

Historic Shares Issued for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $8,000.

  • Entrada Therapeutics' Shares Issued rose 102.04% to $8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.4 million, marking a year-over-year decrease of 196.41%. This contributed to the annual value of $2.8 million for FY2024, which is 134.37% up from last year.
  • Latest data reveals that Entrada Therapeutics reported Shares Issued of $8,000 as of Q3 2025, which was down 60.00% from $20,000 recorded in Q2 2025.
  • Entrada Therapeutics' 5-year Shares Issued high stood at $99.8 million for Q2 2024, and its period low was -$96.8 million during Q4 2024.
  • Its 3-year average for Shares Issued is $395,182, with a median of $206,000 in 2024.
  • Over the last 5 years, Entrada Therapeutics' Shares Issued had its largest YoY gain of 38,714.00% in 2023, and its largest YoY loss of 173,018.18% in 2023.
  • Over the past 4 years, Entrada Therapeutics' Shares Issued (Quarterly) stood at $163,000 in 2022, then skyrocketed by 165.64% to $433,000 in 2023, then plummeted by 22,461.66% to -$96.8 million in 2024, then spiked by 102.04% to $8,000 in 2025.
  • Its Shares Issued stands at $8,000 for Q3 2025, versus $20,000 for Q2 2025 and $350,000 for Q1 2025.